AC Immune Ltd Cash Flow Reinvestment Rate

Latest as of December 2024: 0.66x

AC Immune Ltd cash flow reinvestment rate. AC Immune Ltd (ACIU) has a Cash Flow Reinvestment Rate of 0.66x as of December 2024, reinvesting $3.92 Million (capex $90.00K plus investments $-3.83 Million) from operating cash flow of $5.93 Million. Explore debt repayment capacity of AC Immune Ltd to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.66x
(Capex + Investments) / Operating CF

Total Reinvested

$3.92 Million
Capex + Investments

Operating Cash Flow

$5.93 Million
USD

Capital Expenditures

$90.00K
USD

Cash Flow Reinvestment Rate of AC Immune Ltd (2015–2024)

Cash flow reinvestment rate of AC Immune Ltd from 2015 to 2024. Historical reinvestment intensity for AC Immune Ltd across 3 annual periods. Explore ACIU capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

AC Immune Ltd Cash Flow Reinvestment Rate by Year (2015–2024)

AC Immune Ltd cash flow reinvestment rate by year from 2015 to 2024. Year-by-year capital reinvestment analysis for AC Immune Ltd. For the full cash flow conversion analysis, see AC Immune Ltd operating cash flow efficiency.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 1.61x $105.87 Million $65.84 Million $576.00K ▲ +29.1%
2019 1.25x $68.77 Million $55.22 Million $1.89 Million ▲ +83.0%
2015 0.68x $29.99 Million $44.08 Million $244.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow